Below is a table from of recent NDA and BLA applications to the US Food and Drug Administration based on data from the Pink Sheet’s FDA Performance Tracker. As one might expect, special pathways figure prominently in the submissions.
On The Docket: Recent Submissions For US FDA Approval
Round-up of late summer applications recently submitted to US FDA, adapted from the Pink Sheet FDA Performance Tracker's User Fee Goal Dates chart.